Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $4.38 Million - $6.57 Million
92,866 New
92,866 $6.3 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $235,026 - $503,118
6,600 Added 50.38%
19,700 $776,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $754,036 - $1.08 Million
13,100 New
13,100 $916,000
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $560,180 - $832,973
-5,981 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $697,205 - $927,114
5,981 New
5,981 $788,000
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $6.33 Million - $8.13 Million
-81,504 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $13.2 Million - $17.9 Million
-146,199 Reduced 64.21%
81,504 $7.37 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $787,508 - $1.04 Million
8,798 Added 4.02%
227,703 $26.9 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $13.6 Million - $21.1 Million
218,905 New
218,905 $19 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $968,407 - $1.62 Million
-20,054 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $758,843 - $1.4 Million
20,054 New
20,054 $1.2 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $2.16 Million - $3.12 Million
-54,182 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $2.52 Million - $3.28 Million
54,182
54,182 $2.85 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.